Clinical Trial Update: A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia [Phase 1]

View source ↗

Summary

A Phase 1 study of clofarabine in Japanese pediatric patients with relapsed or refractory acute lymphoblastic leukemia has completed, providing early safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Clolar (Clofarabine)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED